Maven Capital Partners has exited its investment in Crawford Scientific, a leading supplier of chromatography products and analytical services to the laboratory research and testing sectors, following its sale to Limerston Capital Partners I, LP. The sale realised a return for Maven clients of 4.7x the initial investment in just over three years, with an IRR of 70%.